CRISPR Therapeutics AG ( CRSP) - Key Metrics
CRSP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.01 | -$2.40 | -$1.31 | -$1.31 |
| 2025Q1 | $0.01 | -$1.58 | -$0.63 | -$0.63 |
CRSP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -5.08 |
| 2025Q1 | ? | -5.38 |
CRSP
Price: $51.84
52 week price:
Earnings Per Share: -6.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.2 million
Ebitda: -23.2 millionMarket Capitalization: 5.0 billion